Engman et al. compared the use of angiotensin-converting-enzyme inhibition and angiotensin II receptor blockade in experimental autoimmune myocarditis and found that both drugs significantly reduce inflammation, necrosis, and fibrosis in myosin-immunized mice [27]. This evidence concerns the gene MYH14 and autoimmune myocarditis.